Loading…
Reported covered position: Legislative Assistant, Rep. Elijah Cummings (2016-2017); Professional Staff, House Oversight & Reform Committee (2016)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Rescue Plan Act of 2021
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: FORBES-TATE
Issues regarding the implementation of H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: IRON MOUNTAIN INFORMATION MANAGEMENT, LLC · Firm: FORBES-TATE
Issues relating to Department of Defense operations, including records management; Issues regarding the implementation of H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2022 · first_quarter · 1A
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Source: Senate LDA
| AMGEN USA, INC. |
| 13 |
| 2019–2022 |
| BANK OF AMERICA CORPORATION | 13 | 2019–2022 |
| CTIA - THE WIRELESSS ASSOCIATION | 13 | 2019–2022 |
| IRON MOUNTAIN INFORMATION MANAGEMENT, LLC | 13 | 2019–2022 |
| MERCK | 13 | 2019–2021 |
| NATIONAL CABLE TELECOMMUNICATIONS ASSOCIATION | 13 | 2019–2022 |
| PACIFIC GAS AND ELECTRIC | 13 | 2019–2022 |
| VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES | 13 | 2019–2022 |
| WALGREENS CO. | 13 | 2019–2022 |
| NATIONAL HOCKEY LEAGUE | 12 | 2019–2021 |
| SECURE IDENTITY, LLC (DBA CLEAR) | 12 | 2019–2022 |
| UNITED AIRLINES, INC | 12 | 2019–2021 |
| ALTRIA CLIENT SERVICES LLC | 11 | 2019–2022 |
| LIVE NATION ENTERTAINMENT, INC. | 11 | 2019–2022 |
| PHRMA | 11 | 2019–2022 |
| SAREPTA THERAPEUTICS | 11 | 2019–2022 |
| THE PARTNERSHIP FOR AMERICAS HEALTH CARE FUTURE | 11 | 2019–2021 |
| UNITED PARCEL SERVICE | 11 | 2019–2022 |
| ALEXION PHARMACEUTICALS, INC. | 10 | 2020–2022 |
| INTERSTATE NATURAL GAS ASSOCIATION OF AMERICA | 10 | 2019–2021 |
| LILLY USA, LLC | 10 | 2020–2022 |
| NEW VENTURE FUND | 10 | 2019–2022 |
| REGENESIS | 10 | 2020–2022 |
| EMERGENT BIOSOLUTIONS | 9 | 2020–2022 |
| NATIONAL ASSOCIATION OF PROTON THERAPY | 9 | 2020–2022 |
| TYSON SHARED SERVICES, INC. | 9 | 2020–2022 |
| ADVANCED MICRO DEVICES (AMD) | 8 | 2020–2021 |
| COALITION FOR APP FAIRNESS | 8 | 2021–2022 |
| UNIVERSAL MUSIC GROUP RECORDINGS, INC. | 8 | 2020–2022 |
| UNIVERSITY OF SOUTHERN CALIFORNIA | 8 | 2020–2021 |
| WE ARE GOLF | 8 | 2019–2021 |
| EVOLUS BEAUTY | 7 | 2019–2020 |
| GOBRANDS, INC. | 7 | 2020–2022 |
| THE WILLIAMS COMPANIES, INC. | 7 | 2020–2022 |
| GINKGO BIOWORKS | 6 | 2020–2022 |
| VIR BIOTECHNOLOGY, INC. | 6 | 2020–2022 |
| YUM RESTAURANT SERVICES GROUP, LLC | 6 | 2021–2022 |
| COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION | 5 | 2021–2022 |
| GENENTECH | 5 | 2021–2022 |
| HIP-HOPPRENEUR, INC. | 5 | 2020 |
| NEW VENTURE FUND ON BEHALF OF CENTER FOR SECURE AND MODERN ELECTIONS | 5 | 2021–2022 |
| PUBLIC SERVICE ENTERPRISE GROUP | 5 | 2021–2022 |
| REFORMING AMERICA'S TAXES EQUITABLY | 5 | 2021–2022 |
| BELLEROPHON THERAPEUTICS | 4 | 2020 |
| STORER TEST EXPRESS DBA BUSTEST EXPRESS | 4 | 2021–2022 |
| CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. | 3 | 2021–2022 |
| JOBSOHIO | 3 | 2021–2022 |
| NATIONAL ASSOCIATION OF LANDSCAPE PROFESSIONALS | 3 | 2019–2020 |
| NEUTRON HOLDINGS DBA LIME | 3 | 2020 |
| H&R BLOCK | 2 | 2019 |
| ORACLE | 2 | 2021–2022 |
| ANNALY CAPITAL MANAGEMENT, INC. | 1 | 2019 |
| INTERNATIONAL COUNCIL OF SHOPPING CENTERS | 1 | 2022 |
| TRUE VELOCITY | 1 | 2019 |
Issues regarding the implementation of H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Energy issues related to spent nuclear fuel policy and cybersecurity; Issues related to hydroelectric relicensing reform; Issues related to vegetation management; Issues related to cost recovery at FERC; Issues regarding implementation of the Protecting Our Infrastructure of Pipelines and Enhancing Safety Act of 2020 (PIPES Act); Issues related to H.R. 1514/S. 1432 - POWER ON.
Issues related to H.R. 1514/S. 1432 - POWER ON.
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
State Opioid Response Grant Authorization Act of 2021
Client: EMERGENT BIOSOLUTIONS · Firm: FORBES-TATE
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues related to pharmacies, pharmacists, and Medicare reimbursement; H.R.2471 - Consolidated Appropriations Act, 2022, Issues related to Covid funding.
Issues pertaining to prescription drug pricing; Issues related to IPAB; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (Public Law 98-417). Issues regarding implementation of the CREATES Act of 2019 (Public Law No: 116-94); Issues regarding H.R. 985 (116th Congress) - FAST Generics Act of 2019; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues regarding implementation of the CARES Act (Public Law No: 116-136); H.R.2471 - Consolidated Appropriations Act, 2022, Issues related to Covid funding.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues regarding the implementation of H.R. 2471 - Consolidated Appropriations Act of 2022 (Public Law No. 117-103).
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); H.R.2471 - Consolidated Appropriations Act, 2022, Issues related to Covid Funding.
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act.
Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Infrastructure Investment and Jobs Act
Client: CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. · Firm: FORBES-TATE
Issues related to increasing financing options; Issues related to Public-Private Partnerships; Issues related to FAST Act Reauthorization; Issues related to H.R.3684 - Infrastructure Investment and Jobs Act (Public Law: 11758).
Infrastructure Investment and Jobs Act
Client: CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. · Firm: FORBES-TATE
Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Representation regarding H.R.3684 - Infrastructure Investment and Jobs Act Framework
Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022
Client: ALTRIA CLIENT SERVICES LLC · Firm: FORBES-TATE
Appropriations Issues related to H.R.4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022.
United States Innovation and Competition Act of 2021
Client: CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. · Firm: FORBES-TATE
Issues related to FY2022 Energy & Water Appropriations Bills S. 2892 and H.R. 4549. Issues related to competitiveness legislation, including S.1260 - United States Innovation and Competition Act of 2021 and H.R.4521 - America COMPETES Act of 2022.
United States Innovation and Competition Act of 2021
Client: A.O. SMITH CORPORATION · Firm: FORBES-TATE
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to section 301 tariffs; Issues related to H.R.4521 - America COMPETES Act of 2022.
Energy and Water Development and Related Agencies Appropriations Act, 2022
Client: CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. · Firm: FORBES-TATE
Issues related to FY2022 Energy & Water Appropriations Bills S. 2892 and H.R. 4549. Issues related to competitiveness legislation, including S.1260 - United States Innovation and Competition Act of 2021 and H.R.4521 - America COMPETES Act of 2022.
Preventing Overdoses and Saving Lives Act of 2021
Client: EMERGENT BIOSOLUTIONS · Firm: FORBES-TATE
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues related to internal tax and R&D amortization credit in the H.R.5376 - Build Back Better Act; Issues related to tax.
Issues related to corporate tax rate and international tax; infrastructure, budget reconciliation and H.R.5376 - Build Back Better Act.
Issues related to tobacco tax; Issues related to excise tax on tobacco in the HR 5376 - Build Back Better Act.
Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act.
Inflation Reduction Act of 2022
Client: REFORMING AMERICA'S TAXES EQUITABLY · Firm: FORBES-TATE
Issues related to taxation; Issues related to H.R.5376 - Build Back Better Act.
To require online marketplaces to verify certain information regarding high-volume third party sellers of consumer products on such online marketplaces and to disclose to consumers certain contact and other information regarding such high-volume third party sellers.
Client: PERSONAL CARE PRODUCTS COUNCIL · Firm: FORBES-TATE
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products; S.936/H.R. 5502 - INFORM Consumers Act; H.R.6058 (116th Congress)- SHOP SAFE Act of 2020.
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act.
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
United States Innovation and Competition Act of 2021
Client: CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. · Firm: FORBES-TATE
Issues related to FY2022 Energy & Water Appropriations Bills S. 2892 and H.R. 4549. Issues related to competitiveness legislation, including S.1260 - United States Innovation and Competition Act of 2021 and H.R.4521 - America COMPETES Act of 2022.
Energy issues related to spent nuclear fuel policy and cybersecurity; Issues related to hydroelectric relicensing reform; Issues related to vegetation management; Issues related to cost recovery at FERC; Issues regarding implementation of the Protecting Our Infrastructure of Pipelines and Enhancing Safety Act of 2020 (PIPES Act); Issues related to H.R. 1514/S. 1432 - POWER ON.
Issues related to H.R. 1514/S. 1432 - POWER ON.
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
Zero-Emission Nuclear Power Production Credit Act of 2021
Client: PUBLIC SERVICE ENTERPRISE GROUP · Firm: FORBES-TATE
Issues related to Nuclear Production Tax Credit, issues related to climate change; S.2291 - Zero-Emission Nuclear Power Production Credit Act of 2021.
Stop the Shutdowns Transferring Unnecessary Pain and Inflicting Damage In The coming Years Act
Client: CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. · Firm: FORBES-TATE
Issues related to FY2022 Energy & Water Appropriations Bills S. 2892 and H.R. 4549. Issues related to competitiveness legislation, including S.1260 - United States Innovation and Competition Act of 2021 and H.R.4521 - America COMPETES Act of 2022.
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products; S.936/H.R. 5502 - INFORM Consumers Act; H.R.6058 (116th Congress)- SHOP SAFE Act of 2020.
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: LILLY USA, LLC · Firm: FORBES-TATE
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues regarding the implementation of H.R. 2471 - Consolidated Appropriations Act of 2022 (Public Law No. 117-103).
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: LILLY USA, LLC · Firm: FORBES-TATE
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees; COVID 19 therapeutic funding.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: LILLY USA, LLC · Firm: FORBES-TATE
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees, Issues related to Insulin pricing, Issues regarding the 340B Drug Pricing Program; Issues regarding the 2022 reauthorization of the Prescription Drug User Fee Act (PDUFA); Issues regarding Centers for Medicare and Medicaid Services draft National Coverage Decision (NCD) Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease (CAG-00460N).
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: LILLY USA, LLC · Firm: FORBES-TATE
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: LILLY USA, LLC · Firm: FORBES-TATE
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2022 and setting forth the appropriate budgetary levels for fiscal years 2023 through 2031.
Client: NOVARTIS, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Client: AMGEN USA, INC. · Firm: FORBES-TATE
Issues related to prescription drug pricing; Issues related to H.R. 2693 (116th Congress) - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019
Client: LIVE NATION ENTERTAINMENT, INC. · Firm: FORBES-TATE
Issues related to transparency and accountability to ticket sales pricing; H.R. 3248/S. 1850 (116th Congress) - Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019.
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products; S.936/H.R. 5502 - INFORM Consumers Act; H.R.6058 (116th Congress)- SHOP SAFE Act of 2020.
Issues pertaining to prescription drug pricing; Issues related to IPAB; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (Public Law 98-417). Issues regarding implementation of the CREATES Act of 2019 (Public Law No: 116-94); Issues regarding H.R. 985 (116th Congress) - FAST Generics Act of 2019; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019
Client: LIVE NATION ENTERTAINMENT, INC. · Firm: FORBES-TATE
Issues related to transparency and accountability to ticket sales pricing; H.R. 3248/S. 1850 (116th Congress) - Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019.
American Rescue Plan Act of 2021
Client: IRON MOUNTAIN INFORMATION MANAGEMENT, LLC · Firm: FORBES-TATE
Issues relating to Department of Defense operations, including records management; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: FORBES-TATE
Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues related to emergency funding for institutions of higher education in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to college athletics, including name, image, and likeness.
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues related to healthcare and academic medical centers; Issues regarding hospital funding in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to telemedicine; Issues related to Medicare sequester, including H.R. 315 - Medicare Sequester COVID Moratorium Act.
American Rescue Plan Act of 2021
Client: IRON MOUNTAIN INFORMATION MANAGEMENT, LLC · Firm: FORBES-TATE
Issues relating to Department of Defense operations, including records management; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
American Rescue Plan Act of 2021
Client: IRON MOUNTAIN INFORMATION MANAGEMENT, LLC · Firm: FORBES-TATE
Issues relating to Department of Defense operations, including records management; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: IRON MOUNTAIN INFORMATION MANAGEMENT, LLC · Firm: FORBES-TATE
Issues relating to Department of Defense operations, including records management; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues related to emergency funding for institutions of higher education in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to college athletics, including name, image, and likeness.
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
American Rescue Plan Act of 2021
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: FORBES-TATE
Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues related to drug pricing and Section 340B of the Public Health Service Act; Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues related to healthcare and academic medical centers; Issues regarding hospital funding in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to telemedicine; Issues related to Medicare sequester, including H.R. 315 - Medicare Sequester COVID Moratorium Act.
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues related to healthcare and academic medical centers; Issues regarding hospital funding in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to telemedicine; Issues related to Medicare sequester, including H.R. 315 - Medicare Sequester COVID Moratorium Act.
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues related to healthcare and academic medical centers; Issues regarding hospital funding in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to telemedicine; Issues related to Medicare sequester, S. 610 - Protecting Medicare & American Farmers from Sequester Cuts Act.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues related to drug pricing and Section 340B of the Public Health Service Act; Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES · Firm: FORBES-TATE
Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: UNIVERSITY OF SOUTHERN CALIFORNIA · Firm: FORBES-TATE
Issues regarding implementation of provisions related to higher education, research, and student aid relief in the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to emergency funding for institutions of higher education in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to college athletics, including name, image, and likeness.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues related to drug pricing and Section 340B of the Public Health Service Act; Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
American Rescue Plan Act of 2021
Client: LIVE NATION ENTERTAINMENT, INC. · Firm: FORBES-TATE
Issues regarding general COVID-19 response efforts; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
American Rescue Plan Act of 2021
Client: LIVE NATION ENTERTAINMENT, INC. · Firm: FORBES-TATE
Issues regarding employee retention tax credit in the CARES Act (Public Law No: 116-136); Issues regarding employee retention tax credit in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Budget and appropriations issues related to the airline industry; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to the Payroll Support Program and emergency funding for the airline industry.
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS, INC. via FORBES-TATE
2022 · first_quarter · 1A
Issues related to prescription drug pricing; issues related to World Trade Organization IP waiver; issues related to pharmaceutical intellectual property; issues related to international trade.
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees; COVID 19 therapeutic funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. via FORBES-TATE
2022 · first_quarter · 1T
Issues related to FY2022 Energy & Water Appropriations Bills S. 2892 and H.R. 4549. Issues related to competitiveness legislation, including S.1260 - United States Innovation and Competition Act of 2021 and H.R.4521 - America COMPETES Act of 2022.
Issues related to paid family leave proposals.
Issues related to Advanced Research Projects Agency-Energy (ARPA-E) funding.
Issues related to immigration reform.
Issues related to increasing financing options; Issues related to Public-Private Partnerships; Issues related to FAST Act Reauthorization; Issues related to H.R.3684 - Infrastructure Investment and Jobs Act (Public Law: 11758).
Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
YUM RESTAURANT SERVICES GROUP, LLC via FORBES-TATE
2022 · first_quarter · Q1
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Q1
Issues related to pharmacies, pharmacists, and Medicare reimbursement; H.R.2471 - Consolidated Appropriations Act, 2022, Issues related to Covid funding.
Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income; Issues related to global intangible low taxed income (GILTI).
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); H.R.2471 - Consolidated Appropriations Act, 2022, Issues related to Covid Funding.
Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues regarding implementation of the CARES Act (Public Law No: 116-136); H.R.2471 - Consolidated Appropriations Act, 2022, Issues related to Covid funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIR BIOTECHNOLOGY, INC. via FORBES-TATE
2022 · first_quarter · Q1
Healthcare initiatives related to novel antibody technology platform; Issues related to COVID funding; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Healthcare initiatives related to novel antibody technology platform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via FORBES-TATE
2022 · first_quarter · Q1
Issues regarding the implementation of H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to tariffs.
Issues related to spectrum auctions, net neutrality, infrastructure deployment, privacy, and 5G deployment.
VERDE TECHNOLOGIES via FORBES-TATE
2022 · first_quarter · 1T
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
UNIVERSAL MUSIC GROUP RECORDINGS, INC. via FORBES-TATE
2022 · first_quarter · Q1
Monitoring potential legislation regarding copyright and licensing.
Monitoring potential legislation regarding copyright and licensing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED PARCEL SERVICE via FORBES-TATE
2022 · first_quarter · Q1
Issues related to corporate tax rate and international tax; infrastructure, budget reconciliation and H.R.5376 - Build Back Better Act.
Issues related to OSHA and Emergency Temporary Standard for employer vaccine mandates.
Issues related to postal reform; Issues related to postal service.
TYSON SHARED SERVICES, INC. via FORBES-TATE
2022 · first_quarter · Q1
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
THE WILLIAMS COMPANIES, INC. via FORBES-TATE
2022 · first_quarter · Q1
Issues related to natural gas pipelines.
Issues related to natural gas pipelines.
Issues related to natural gas pipelines.
STORER TEST EXPRESS DBA BUSTEST EXPRESS via FORBES-TATE
2022 · first_quarter · Q1
Issues related to Appropriations, COVID Relief Funds, HRSA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS via FORBES-TATE
2022 · first_quarter · 1T
Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases; Issues related to newborn screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Q1
Issues related to prescription drug pricing.
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.5376 - Build Back Better Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REGENESIS via FORBES-TATE
2022 · first_quarter · 1T
Issues related to Appropriations.
Issues related to PFAS substances.
Issues related to PFAS substances; Issues regarding implementation of the National Defense Authorization Act for Fiscal Year 2021 (Public Law No: 116-283).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFORMING AMERICA'S TAXES EQUITABLY via FORBES-TATE
2022 · first_quarter · Q1
Issues related to taxation; Issues related to H.R.5376 - Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC SERVICE ENTERPRISE GROUP via FORBES-TATE
2022 · first_quarter · Q1
Issues related to Nuclear Production Tax Credit, issues related to climate change.
Issues related to Nuclear Production Tax Credit, issues related to climate change; S.2291 - Zero-Emission Nuclear Power Production Credit Act of 2021.
Issues related to Nuclear Production Tax Credit, issues related to climate change.
PHRMA via FORBES-TATE
2022 · first_quarter · Q1
Issues pertaining to prescription drug pricing.
Issues pertaining to prescription drug pricing; Issues related to IPAB; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (Public Law 98-417). Issues regarding implementation of the CREATES Act of 2019 (Public Law No: 116-94); Issues regarding H.R. 985 (116th Congress) - FAST Generics Act of 2019; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to Section 340B of the Public Health Service Act; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
PERSONAL CARE PRODUCTS COUNCIL via FORBES-TATE
2022 · first_quarter · Q1
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products; S.936/H.R. 5502 - INFORM Consumers Act; H.R.6058 (116th Congress)- SHOP SAFE Act of 2020.
Issues related to implementation of FY21 AG-FDA Appropriations; Issues related to sunscreen use; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to animal testing ban.
PACIFIC GAS AND ELECTRIC via FORBES-TATE
2022 · first_quarter · Q1
Energy issues related to spent nuclear fuel policy, cybersecurity, and physical security.
Energy issues related to spent nuclear fuel policy and cybersecurity; Issues related to hydroelectric relicensing reform; Issues related to vegetation management; Issues related to cost recovery at FERC; Issues regarding implementation of the Protecting Our Infrastructure of Pipelines and Enhancing Safety Act of 2020 (PIPES Act); Issues related to H.R. 1514/S. 1432 - POWER ON.
Issues related to supplemental appropriations due to wildfires.
ORACLE via FORBES-TATE
2022 · first_quarter · Q1
Issues related to cybersecurity; Issues related to privacy; Issues related to data protection.
Issues related to intellectual property protection; Issues regarding the implementation of tax reform (Public Law No: 115-97) as related to international taxes; Issues related to health exchanges and the Affordable Care Act.
Issues related to health exchanges and the Affordable Care Act (Public Law No: 111-148); Issues related to health.
NOVARTIS, INC. via FORBES-TATE
2022 · first_quarter · Q1
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to H.R.2471 - Consolidated Appropriations Act, 2022.
NEW VENTURE FUND ON BEHALF OF CENTER FOR SECURE AND MODERN ELECTIONS via FORBES-TATE
2022 · first_quarter · Q1
Issues related to elections infrastructure funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW VENTURE FUND via FORBES-TATE
2022 · first_quarter · Q1
Issues related to maternal health.
Issues related to maternal health.
Issues related to maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CABLE & TELECOMMUNICATIONS ASSOCIATION via FORBES-TATE
2022 · first_quarter · Q1
Issues related to rural broadband coverage; Issues related to Rural Utilities Service Broadband; Issues related to privacy; Issues related to broadband mapping.
Issues related to infrastructure; Issues related to broadband.
Issues related to cyber intelligence; Issues related to net neutrality.
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2022 · first_quarter · Q1
Issues regarding access to proton therapy; Issues regarding the Radiation Oncology Alternative Payment Model (RO APM).
Issues regarding access to proton therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
LIVE NATION ENTERTAINMENT, INC. via FORBES-TATE
2022 · first_quarter · Q1
Issues related to transparency and accountability to ticket sales pricing; H.R. 3248/S. 1850 (116th Congress) - Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019.
Issues related to safety and security surrounding Venues.
Issues related to transparency and accounting related to ticket sales pricing; Issues related to anti-trust enforcement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LILLY USA, LLC via FORBES-TATE
2022 · first_quarter · Q1
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues regarding the implementation of H.R. 2471 - Consolidated Appropriations Act of 2022 (Public Law No. 117-103).
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
JOBSOHIO via FORBES-TATE
2022 · first_quarter · Q1
Issues related to economic development, job creation, job retention, job training, workforce development, and the retention of current business, and recruitment of new business, to Ohio.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2022 · first_quarter · Q1
Issues related to issues related to tax treatment of REITS (Real Estate Investment Trust).
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage.
Issues related to federal records management; Issues related to federal background checks.
INTERNATIONAL COUNCIL OF SHOPPING CENTERS via FORBES-TATE
2022 · first_quarter · Q1
Issues related to organized retail crime.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Q1
Issues pertaining to gig economy workers and related status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GINKGO BIOWORKS via FORBES-TATE
2022 · first_quarter · Q1
Issues related to synthetic biology.
Issues related to synthetic biology.
Issues related to bio-security.
Issues related to pooled school testing.
GENENTECH via FORBES-TATE
2022 · first_quarter · Q1
Issues related to internal tax and R&D amortization credit in the H.R.5376 - Build Back Better Act; Issues related to tax.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D.
Intellectual property and process patent related issues.
EMERGENT BIOSOLUTIONS via FORBES-TATE
2022 · first_quarter · Q1
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
CTIA - THE WIRELESS ASSOCIATION via FORBES-TATE
2022 · first_quarter · Q1
Issues related to broadband spectrum policy, the incentive auction, net neutrality, 5G deployment, rural broadband, and privacy; Supply chain related issues.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to cybersecurity, broadcaster repacking, spectrum legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2022 · first_quarter · Q1
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
COALITION FOR APP FAIRNESS via FORBES-TATE
2022 · first_quarter · Q1
Issues related to anti-trust legislation.
Issues related to anti-trust legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYER CORPORATION via FORBES-TATE
2022 · first_quarter · Q1
Issues related to drug pricing; Issues related to 340b; Issues related to trade; Issues related to tax.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BANK OF AMERICA CORPORATION via FORBES-TATE
2022 · first_quarter · 1T
General issues related to banking.
Issues regarding the implementation of H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2022 · first_quarter · Q1
Issues related to Biosimilars.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to the implementation of international tax and tax reform (Public Law No: 115-97); Issues related to Puerto Rico tax.
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2022 · first_quarter · Q1
Issues related to tobacco tax; Issues related to excise tax on tobacco in the HR 5376 - Build Back Better Act.
Issues related to predicate date of electric cigarettes newly deemed tobacco products.
Appropriations Issues related to H.R.4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2022 · first_quarter · Q1
Issues related to healthcare, including drug pricing and Medicare Part D.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit and issues related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECURE IDENTITY, LLC DBA CLEAR via FORBES-TATE
2022 · first_quarter · Q1
Issues related to biometric identification.
Issues related to biometric identification; Issues pertaining to the registered traveler program.
Issues related to biometric identity and health information technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
A.O. SMITH CORPORATION via FORBES-TATE
2022 · first_quarter · Q1
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to section 301 tariffs; Issues related to H.R.4521 - America COMPETES Act of 2022.
Representation regarding H.R.3684 - Infrastructure Investment and Jobs Act Framework
A.O. SMITH CORPORATION via FORBES-TATE
2021 · fourth_quarter · 4A
Issues regarding implementation of the National Defense Authorization Act for Fiscal Year 2021 (Public Law No: 116-283).
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to section 301 tariffs.
Representation regarding H.R.3684 - Infrastructure Investment and Jobs Act Framework
A.O. SMITH CORPORATION via FORBES-TATE
2021 · third_quarter · 3A
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation. .
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
UNIVERSITY OF SOUTHERN CALIFORNIA via FORBES-TATE
2021 · fourth_quarter · 4T
Issues related to FY 2022 Defense Appropriations; Issues related to funding for university research and UARCs.
Issues related to emergency funding for institutions of higher education in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to college athletics, including name, image, and likeness.
Issues regarding FY 2022 Department of Defense Appropriations as related to defense research; Issues pertaining to defense research funding and research security in H.R. 4350 - National Defense Authorization Act for Fiscal Year 2022.
VIR BIOTECHNOLOGY, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Healthcare initiatives related to novel antibody technology platform.
Healthcare initiatives related to novel antibody technology platform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERDE TECHNOLOGIES via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
UNIVERSAL MUSIC GROUP RECORDINGS, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to copyright.
Issues related to copyright.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED PARCEL SERVICE via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to corporate tax rate and international tax; infrastructure, budget reconciliation and H.R.5376 - Build Back Better Act.
Issues related to OSHA and Emergency Temporary Standard for employer vaccine mandates.
General trucking-related issues.
TYSON SHARED SERVICES, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
STORER TEST EXPRESS DBA BUSTEST EXPRESS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to Appropriations, COVID Relief Funds, HRSA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Q4
Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act.
Issues related to orphan drug tax credit; Issues related to H.R.5376 - Build Back Better Act
Issues related to prescription drug pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REGENESIS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to Appropriations.
Issues related to PFAS substances.
Issues related to PFAS substances; Issues regarding implementation of the National Defense Authorization Act for Fiscal Year 2021 (Public Law No: 116-283).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REFORMING AMERICA'S TAXES EQUITABLY via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to taxation; Issues related to H.R.5376 - Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PUBLIC SERVICE ENTERPRISE GROUP via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to Nuclear Production Tax Credit, issues related to climate change.
Issues related to Nuclear Production Tax Credit, issues related to climate change; S.2291 - Zero-Emission Nuclear Power Production Credit Act of 2021.
Issues related to Nuclear Production Tax Credit, issues related to climate change.
PERSONAL CARE PRODUCTS COUNCIL via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products; H.R. 5279 (116th Congress) - Cosmetic Safety Enhancement Act of 2019.
Issues related to implementation of FY21 AG-FDA Appropriations; Issues related to sunscreen use; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products; S.936/H.R. 5502 - INFORM Consumers Act; H.R.6058 (116th Congress)- SHOP SAFE Act of 2020.
PACIFIC GAS AND ELECTRIC via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Energy issues related to spent nuclear fuel policy, cybersecurity, and physical security.
Issues related to H.R. 1514/S. 1432 - POWER ON.
NEW VENTURE FUND via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to maternal health.
Issues related to maternal health.
Issues related to maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW VENTURE FUND ON BEHALF OF CENTER FOR SECURE AND MODERN ELECTIONS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to elections infrastructure funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2021 · fourth_quarter · Q4
Issues regarding access to proton therapy; Issues regarding the Radiation Oncology Alternative Payment Model (RO APM).
Issues regarding access to proton therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
JOBSOHIO via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to economic development, job creation, job retention, job training, workforce development, and the retention of current business, and recruitment of new business, to Ohio
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Q4
Issues pertaining to gig economy workers and related status.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GINKGO BIOWORKS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to synthetic biology.
Issues related to pooled school testing.
Issues related to synthetic biology.
Issues related to bio-security.
EMERGENT BIOSOLUTIONS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues regarding State Opioid Response Grant funding; Issues regarding Substance Abuse and Mental Health Block Grant funding; S. 987 - Comprehensive Addiction and Recovery Act (CARA) 3.0; H.R. 2379 -State Opioid Response Grant Authorization Act of 2021; H.R 2366/S.1457 - Stop Fentanyl Act, H.R. 5224 - Preventing Overdoses and Saving Lives Act of 2021; Issues related to the development, manufacture, and distribution of coronavirus vaccines; H.R.4350/S.2792 - National Defense Authorization Act for Fiscal Year 2022 - provisions related to biological and chemical defense and access to naloxone; Appropriations funding for Fiscal Year 2022, HR 6119 - Further Extending Government Funding Act.
H.R.4350/S.2792 - National Defense Authorization Act for Fiscal Year 2022, provisions related to biological and chemical defense and access to naloxone; Issues regarding opioid and heroin addiction legislation, naloxone access and awareness, and opioid prescribing guidelines; Issues related to the development, manufacture, and distribution of coronavirus vaccines; Outreach regarding H.R. 3263 - DHS Medical Countermeasures Act.
CTIA - THE WIRELESS ASSOCIATION via FORBES-TATE
2021 · fourth_quarter · Q4
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Tax issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14).
Issues related to broadband spectrum policy, the incentive auction, net neutrality, 5G deployment, rural broadband, and privacy; Supply chain related issues.
COALITION FOR CANNABIS POLICY, EDUCATION, AND REGULATION via FORBES-TATE
2021 · fourth_quarter · Q4
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
COALITION FOR APP FAIRNESS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to anti-trust legislation.
Issues related to anti-trust legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAPITOL SOLUTIONS ON BEHALF OF BIPARTISAN POLICY CENTER ADVOCACY NETWORK, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Issues related to ARPA-E funding; Issues related to energy innovation.
Issues related to immigration reform.
BAYER CORPORATION via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to drug pricing; Issues related to 340b; Issues related to trade; Issues related to tax; Issues related to pesticides.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to anti-trust.
Issues related to healthcare, including drug pricing and Medicare Part D.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit and issues related to rare disease.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SECURE IDENTITY, LLC DBA CLEAR via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to biometric identification; Issues pertaining to the registered traveler program.
Issues related to biometric identity and health information technology.
Issues related to biometric identification.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADVANCED MICRO DEVICES (AMD) via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to the semiconductor industry, including in the FY 2022 National Defense Authorization Act (HR 4350).
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing.
Issues related to advanced deisgn tax credit; Issues related to semiconductor tax credits in H.R.5376 - Build Back Better Act.
A.O. SMITH CORPORATION via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues regarding implementation of the National Defense Authorization Act for Fiscal Year 2021 (Public Law No: 116-283).
YUM RESTAURANT SERVICES GROUP, LLC via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
2021 · fourth_quarter · Q4
Issues related to pharmacies, pharmacists, and Medicare reimbursement.
Issues related to pharmacies, pharmacists, Medicare reimbursement, and opioids; Issues regarding implementation of the CARES Act (Public Law No: 116-136).
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to spectrum auctions, net neutrality, infrastructure deployment, privacy, and 5G deployment.
Issues related to accelerated depreciation; Issues related to infrastructure deployment.
Issues related to tariffs.
THE WILLIAMS COMPANIES, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to natural gas pipelines.
Issues related to natural gas pipelines.
Issues related to natural gas pipelines.
SAREPTA THERAPEUTICS via FORBES-TATE
2021 · fourth_quarter · Q4
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases; Issues related to newborn screening.
Issues related to Medicare and Medicaid reimbursement; Issues related to rare diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via FORBES-TATE
2021 · fourth_quarter · Q4
Issues pertaining to prescription drug pricing.
Issues related to Direct to Consumer (DTC) Advertising.
Issues pertaining to prescription drug pricing; Issues related to IPAB; Medicare Part D; Importation of drugs; Issues related to 340b; Issues related to Drug Price Competition and Patent Term Restoration Act (Public Law 98-417). Issues regarding implementation of the CREATES Act of 2019 (Public Law No: 116-94); Issues regarding H.R. 985 (116th Congress) - FAST Generics Act of 2019; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues related to Section 340B of the Public Health Service Act.
ORACLE via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to copyright legislation.
Issues related to cybersecurity; Issues related to privacy; Issues related to data protection.
Issues related to trade and counterfeiting; Issues related to the implementation of tax reform (Public Law No: 115-97).
NOVARTIS, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues related to drug pricing and Section 340B of the Public Health Service Act; Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
NATIONAL CABLE & TELECOMMUNICATIONS ASSOCIATION via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to infrastructure; Issues related to broadband.
Issues related to cyber intelligence; Issues related to net neutrality.
Issues related to Section 616 of the Communications Act (47 U.S.C. 616) regarding program carriage; Issues related to rural broadband coverage; Issues related to Rural Utilities Service Broadband; Issues related to privacy; Issues related to broadband mapping.
MERCK via FORBES-TATE
2021 · fourth_quarter · 4T
Issues related to prescription drug pricing, vaccines, animal health, and maternal health.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines.
LIVE NATION ENTERTAINMENT, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to transparency and accountability to ticket sales pricing; H.R. 3248/S. 1850 (116th Congress) - Better Oversight of Secondary Sales and Accountability in Concert Ticketing Act of 2019.
Issues related to safety and security surrounding Venues.
Issues related to transparency and accounting related to ticket sales pricing; Issues related to anti-trust enforcement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LILLY USA, LLC via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260); Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
IRON MOUNTAIN INFORMATION MANAGEMENT, LLC via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to federal records management; Issues related to federal background checks.
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (Public Law No: 113-291).
Issues related to federal records management; Issues related to House Transportation and Infrastructure Committee Resolution regarding Prospectus PPA-FBC-BO17; Issues related to federal record storage.
GENENTECH via FORBES-TATE
2021 · fourth_quarter · Q4
Intellectual property and process patent related issues.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D.
Tax related issues.
BANK OF AMERICA CORPORATION via FORBES-TATE
2021 · fourth_quarter · Q4
General issues related to banking.
Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2021 · fourth_quarter · Q4
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to the implementation of international tax and tax reform (Public Law No: 115-97); Issues related to Puerto Rico tax.
Issues related to prescription drug pricing; Issues related to H.R. 2693 (116th Congress) - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
ALTRIA CLIENT SERVICES LLC via FORBES-TATE
2021 · fourth_quarter · Q4
Issues related to predicate date of electric cigarettes newly deemed tobacco products.
Appropriations Issues related to H.R.4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022.
Issues related to tobacco tax; Issues related to excise tax on tobacco in the HR 5376 - Build Back Better Act.
JOBSOHIO via FORBES-TATE
2021 · fourth_quarter · RR
Issues related to economic development, job creation, job retention, job training, workforce development, and the retention of current business, and recruitment of new business, to Ohio.
NATIONAL HOCKEY LEAGUE via FORBES-TATE
2021 · fourth_quarter · 4T
Issues related to sports.
Issues related to taxation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STORER TEST EXPRESS DBA BUSTEST EXPRESS via FORBES-TATE
2021 · third_quarter · Q3
Issues related to Appropriations, COVID Relief Funds, HRSA.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
YUM RESTAURANT SERVICES GROUP, LLC via FORBES-TATE
2021 · third_quarter · Q3
Issues related to TCJA, labor requirements, and privacy/data collection.
Issues related to TCJA, labor requirements, and privacy/data collection.
Issues related to TCJA, labor requirements, and privacy/data collection.
VIR BIOTECHNOLOGY, INC. via FORBES-TATE
2021 · third_quarter · Q3
Healthcare initiatives related to novel antibody technology platform.
Healthcare initiatives related to novel antibody technology platform.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VERDE TECHNOLOGIES via FORBES-TATE
2021 · third_quarter · Q3
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to accelerated depreciation; Issues related to infrastructure deployment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to OSHA and Emergency Temporary Standard for employer vaccine mandates.
General trucking-related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to natural gas pipelines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Nuclear Production Tax Credit, issues related to climate change.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to prescription drug pricing.
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines.
Issues related to Direct to Consumer (DTC) Advertising.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to FDA regulation of cosmetics; Issues related to cosmetics and other personal care products.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Appropriations related to energy resiliency in tribal communities; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to cybersecurity.
Issues related to H.R. 1514/S. 1432 - POWER ON.
Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to intellectual property protection; Issues related to international taxes.
Issues related to technology; Issues related to government contracting; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to copyright legislation.
Issues related to trade and counterfeiting; Issues related to the implementation of tax reform (Public Law No: 115-97).
Issues related to technology; Issues related to government contracting; Issues related to implementation of Defense funding in FY21 appropriations.
Issues related to labor.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees, Issues related to Insulin pricing, Issues regarding the 340B Drug Pricing Program; Issues regarding the 2022 reauthorization of the Prescription Drug User Fee Act (PDUFA); Issues regarding Centers for Medicare and Medicaid Services draft National Coverage Decision (NCD) Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimers Disease (CAG-00460N).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Privacy and data security legislation related to consumer data breach notification.
Issues relating to Department of Defense operations, including records management; Issues regarding the implementation of H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Issues related to consolidation of federal data centers under the Federal Information Technology Acquisition and Reform Act (Public Law No: 113-291).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding the Center for Medicare and Medicaid Innovation.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues related to H.R. 2693 (116th Congress) - To amend title XVIII of the Social Security Act to improve access to, and utilization of, bone mass measurement benefits under part B of the Medicare program by establishing a minimum payment amount under such part for bone mass measurement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding implementation of the National Defense Authorization Act for Fiscal Year 2021 (Public Law No: 116-283).
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to the Clean Water for All initiative.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation. .
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to the Clean Water for All initiative.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to the Clean Water for All initiative.
Representation regarding H.R.3684 - Infrastructure Investment and Jobs Act Framework.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to section 301 tariffs.
Issues regarding implementation of the National Defense Authorization Act for Fiscal Year 2021 (Public Law No: 116-283).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to OSHA and private employer vaccine mandates.
Issues related to healthcare and academic medical centers; Issues regarding hospital funding in H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to telemedicine; Issues related to Medicare sequester, S. 610 - Protecting Medicare & American Farmers from Sequester Cuts Act.
Issues related to funding for research, including the University Transportation Centers Program, in PL 117-58, the Infrastructure Investment and Jobs Act; Issues regarding FY 2022 Transportation Housing & Urban Development Appropriations as related to University transportation centers and transportation research; Infrastructure Investment and Jobs Act H.R. 3684 - INVEST in America Act.
Issues related to scientific research in the S.1260 - United States Innovation and Competition Act of 2021.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to funding for domestic infrastructure, H.R.3684 - Infrastructure Investment and Jobs Act.
Issues related to OSHA and Emergency Temporary Standard for employer vaccine mandates.
Issues related to postal reform; Issues related to postal service.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to workplace standards; Issues related to increased testing capacity; Issues related to livestock and food pricing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Nuclear Production Tax Credit, issues related to climate change.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding implementation of the CARES Act (Public Law No: 116-136); Issues related to Internal Revenue Code 45B (Clinical Testing Expenses for Certain Drugs for Rare Diseases or Conditions); Issues related to H.R.5376 - Build Back Better Act.
Issues related to animal testing ban.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues related to cybersecurity.
Energy issues related to spent nuclear fuel policy and cybersecurity; Issues related to hydroelectric relicensing reform; Issues related to vegetation management; Issues related to cost recovery at FERC; Issues regarding implementation of the Protecting Our Infrastructure of Pipelines and Enhancing Safety Act of 2020 (PIPES Act); Issues related to H.R. 1514/S. 1432 - POWER ON.
Appropriations related to energy resiliency in tribal communities; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to supplemental appropriations due to wildfires.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
Issues related to cybersecurity, broadcaster repacking, spectrum legislation; Issues regarding H.R.4350/S.2792 - National Defense Authorization Act for Fiscal Year 2022.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Issues pertaining to government-wide federal regulation of cannabis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to increasing financing options; Issues related to Public-Private Partnerships; Issues related to FAST Act Reauthorization; Issues related to H.R.3684 - Infrastructure Investment and Jobs Act.
Issues related to FY2022 Energy & Water Appropriations Bills S. 2892 and H.R. 4549.
Issues related to paid family leave proposals.
Issues related to Advanced Research Projects Agency-Energy (ARPA-E) funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to supply chain.
Issues related to the semiconductor industry; Issues related to trade; Issues related to manufacturing; Issues related to S.1260 - United States Innovation and Competition Act of 2021, S. 1260; Issues related to S.2107 - FABS Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to the Clean Water for All initiative.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; Issues related to section 301 tariffs.
Issues related to energy efficiency and drinking water policy; Issues related to per- and polyfluoroalkyl substances (PFAS) legislation; H.R. 2975/S. 1645 - Womens Health Protection Act of 2019 (116th Congress) .
Representation regarding H.R.3684 - Infrastructure Investment and Jobs Act Framework
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Issues related to Tax Cuts and Jobs Act (Public Law No: 115-97) implementation, labor requirements, and privacy/data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to pharmacies, pharmacists, and Medicare reimbursement; Issues regarding Section 965 - Treatment of Deferred Foreign Income; Issues related to global intangible low taxed income (GILTI).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to natural gas pipelines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to prescription drug pricing.
Issues related to data exclusivity under the United States Mexico Canada Agreement (USMCA); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to technology; Issues related to government contracting; Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues related to intellectual property protection; Issues regarding the implementation of tax reform (Public Law No: 115-97) as related to international taxes; Issues related to health exchanges and the Affordable Care Act.
Issues related to intellectual property protection; Issues related to international taxes.
Issues related to technology; Issues related to government contracting; Issues related to implementation of Defense funding in FY21 appropriations.
Issues related to health exchanges and the Affordable Care Act (Public Law No: 111-148); Issues related to health.
Issues related to labor.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instruction to Committees.
Issues related to prescription drug pricing; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2); Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing, vaccines, animal health, and maternal health; Issues related to Section 340B of the Public Health Service Act.
Issues related to prescription drug pricing, vaccines, animal health, and maternal health.
Issues related to prescription drug pricing, vaccines, animal health, and maternal health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Issues related to prescription drug pricing reform legislation; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Privacy and data security legislation related to consumer data breach notification.
Issues relating to Department of Defense operations, including records management; Issues regarding H.R. 1319 - American Rescue Plan Act of 2021 (Public Law No: 117-2).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (Public Law No: 116-260).
Issues regarding the Center for Medicare and Medicaid Innovation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to TCJA, labor requirements, and privacy/data collection.
Issues related to TCJA, labor requirements, and privacy/data collection.
Issues related to TCJA, labor requirements, and privacy/data collection.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Issues related to healthcare, the environment, law enforcement, and the pharmaceutical industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE